Table 1.
Main clinical and demographic characteristics of patients with chronic viral hepatitis n (%)
| Characteristics | All patients(n = 134) | Patients with chronic hepatitis C (n = 102) |
| Sex, females | 29 (23.4) | 20 (21.3) |
| Age, yr (SD) | 43.70 (11.4) | 45.2 (11.0) |
| BMI, kg/m2 (SD) | 25.1 (4.5) | 25.2 (4.9) |
| AST, IU/L (IQR) | 46 (26-78) | 46 (30-83) |
| ALT, IU/L (IQR) | 69 (41-122) | 70 (43-127) |
| Alkaline phosphatase, IU/L (IQR) | 69 (59-87) | 70 (59-95) |
| GGT, IU/L (IQR) | 49 (26-80) | 50 (36-88) |
| Total bilirubin, M/L (IQR) | 0.62 (0.46-0.94) | 0.60 (0.44-0.89) |
| Platelet count, 103/mm3 (SD) | 227.8 (76.0) | 227.7 (70.1) |
| Prothrombin time, % (SD) | 94.0 (15.5) | 94.4 (17.0) |
| HCV infection | 102 (76.1) | - |
| HBV infection | 28 (20.9) | - |
| Other1 | 4 (3.0) | - |
| Fibrosis score (METAVIR)2 | ||
| F0 | 14 (10.5) | 6 (5.9) |
| F1 | 56 (42.1) | 44 (43.6) |
| F2 | 29 (21.8) | 24 (23.8) |
| F3 | 20 (15.0) | 17 (16.8) |
| F4 | 14 (10.5) | 10 (9.9) |
| Activity grade (METAVIR) | ||
| A0 | 12 (9.0) | 5 (4.9) |
| A1 | 77 (58.0) | 57 (56.4) |
| A2 | 28 (21.0) | 27 (26.7) |
| A3 | 16 (12.0) | 12 (11.9) |
| Steatosis grade | ||
| S0 | 83 (62.4) | 62 (61.3) |
| S1 | 30 (22.6) | 23 (22.8) |
| S2 | 16 (12.0) | 12 (11.9) |
| S3 | 4 (3.0) | 4 (4.0) |
| LSM, kPa (IQR) | 6.6 (5.0-8.9) | 6.5 (5.0-8.9) |
| PSWE, kPa (IQR) | 5.3 (3.9-6.6) | 5.2 (3.9-6.6) |
1
HCV/HBV coinfection: n = 2; HCV/HIV coinfection: n = 2;
2
Data for one patient missing due to inadequate biopsy specimen length. SD values represent means, and IQR values represent medians. BMI: Body mass index; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transferase; LSM: Liver stiffness measurement; PSWE: Point shear wave elastography.